about
Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan.Primary prevention of cardiovascular disease in a primary care setting.Interaction sites of the G protein beta subunit with brain G protein-coupled inward rectifier K+ channel.Variable omeprazole kinetics in healthy Jordanian adults.Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan.Role of clinical pharmacist in the management of blood pressure in dialysis patients.Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women.Calcium phosphate-mediated transfection of primary cultured brain neurons using GFP expression as a marker: application for single neuron electrophysiology.Dominant negative effects of a Gbeta mutant on G-protein coupled inward rectifier K+ channel.Evaluation of venous thromboembolism prophylaxis after the introduction of an institutional guideline: Extent of application and implementation of its recommendations.Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacistPharmacy in JordanThe role of clinical pharmacist on lipid control in dyslipidemic patients in North of JordanEvaluation of VTE Prophylaxis in an Educational Hospital: Comparison Between the Institutional Guideline (Caprini 2006) and the ACCP Guideline (Ninth Edition)Evaluating unfractionated heparin fixed dosing protocol and establishing an institutional therapeutic range for UFH in hospital setting in Jordan
P50
Q37410930-5F1A5E70-86F8-48AA-AFAE-9A04F75991D5Q40259560-9E487908-4674-4858-9244-D4CA4AD0C25DQ40816628-CA1F072E-779D-41A2-8001-29A9B55D8772Q46500673-E6C66E86-1898-4CCE-84CC-36DA0850BE15Q46678656-BDC97D0E-157C-4070-85F2-CB024A1652B0Q47793990-589BEF1C-49A3-407C-97EA-DBE53A0CDB35Q48161033-257C3F2E-D54E-4F78-9DBD-C1B5D9C22CA7Q48252748-867659FA-C79B-48E8-9901-1FA46C10A0C6Q48488375-B9635CFB-D1F4-44A6-A1F7-986865CDA4CFQ50549913-17B43747-FAF9-449B-9462-6E7C803EDB85Q57312185-D74C7B81-3E57-46F5-B3A3-ED2C349F5750Q81517054-513D4733-B4C5-430E-B0C0-FBD95EEAD18BQ84535065-5D38BEFF-14C4-476F-B137-F0568E980947Q86892730-E1288719-3D47-48D5-97D2-E80E983D0147Q95404843-4CD70EF0-1126-44EF-ADE9-585AC6A4520C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4749-4066
@en
name
Abla Albsoul-Younes
@ast
Abla Albsoul-Younes
@en
Abla Albsoul-Younes
@es
Abla Albsoul-Younes
@nl
type
label
Abla Albsoul-Younes
@ast
Abla Albsoul-Younes
@en
Abla Albsoul-Younes
@es
Abla Albsoul-Younes
@nl
prefLabel
Abla Albsoul-Younes
@ast
Abla Albsoul-Younes
@en
Abla Albsoul-Younes
@es
Abla Albsoul-Younes
@nl
P106
P1153
6602217383
P31
P496
0000-0002-4749-4066